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Abstract
Introduction. Andropause and aging are associated with neuroendocrine dysfunctions. Growth hormone and testosterone 
play a significant role in several processes affecting adaptation and thereby also everyday functioning. The aim of this 
research project was to evaluate the effects of recombinant human growth hormone and testosterone enanthate injections 
on body mass and body composition, aerobic and anaerobic fitness and lipid profile in middle-aged men.   
Materials and method. The research group was comprised of 14 men aged 45 – 60 years. Two series of laboratory analyses 
were performed. Independent tests were carried out at baseline and after 12 weeks of the experiment. The data were 
analyzed using Statistica 9.1 software.   
Results. A two-way repeated measures ANOVA revealed a statistically significant effect of the intervention programme on 
fat-free mass (η2=0.34), total body fat (η2=0.79), total cholesterol (η2=0.30), high-density lipoprotein cholesterol (η2=0.31), 
low-density lipoprotein cholesterol (η2=0.42), triglyceride (η2=0.28), testosterone (η2=0.52), insulin-like growth factor 1 
(η2=0.47) and growth hormone (η2=0.63). Furthermore, ANOVA revealed a statistically significant effect of the rhGH and T 
treatment on maximal oxygen uptake (η2=0.63), anaerobic threshold (η2=0.61) and maximal work rate (η2=0.53).   
Conclusion. It should be emphasized that the lipid profile was affected not only by rhGH+T replacement therapy, but 
also by the prescribed physical activity programme. The strength and endurance fitness programme alone did not cause 
significant changes in body mass and composition, nor the anaerobic and aerobic capacity. On the other hand, the rhGH=T 
treatment stimulated these changes significantly.
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INTRODUCTION
Andropause, sarcopenia and aging are associated with 
neuroendocrine dysfunctions. Age-related endocrine 
deficiencies and changes in endocrine function decrease the 
quality of life, which is associated with a decrease in skeletal 
muscle mass and strength. Growth hormone (GH) and 
testosterone (T) play a significant role in several processes 
affecting adaptation and thereby also everyday functioning. 
The anabolic and lipolytic effects of GH have been well 
documented among healthy and GH-deficient subjects 
(GHD) [1]. Testosterone is the principal male sex hormone 
from the androgen group. It is produced by interstitial cells 
of Leydig in the testes in the presence of luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH). Testosterone 
is an anabolic hormone directly affecting increases in muscle 
mass and strength [2]. A relationship has been found between 
testosterone concentration and muscle satellite cell increase. 
Testosterone regulates body composition by promoting the 
commitment of mesenchymal pluripotent cells into myogenic 
lineage and inhibiting the differentiation into adipogenic 
lineage via an androgen receptor-mediated pathway[3].
Apart from the decline in GH and T secretion with 
increasing age, hormonal response to physical exercise is 
also lowered, resulting in partial or complete loss of training-
induced physiological adaptations [4, 5]. It has been shown 
that the acute GH response is somewhat limited in older 
individuals [4]. Hakkinen & Pakarinen [5] demonstrated 
that a heavy resistance training session caused an increase in 
testosterone concentration in 30 and 50 year old men, but not 
in elderly subjects. Adults with GH deficiency and testosterone 
dysfunction exhibited a significantly reduced quadriceps 
muscle strength, compared to a group with physiological 
levels of GH and T. Since muscle strength reduction among 
individuals with GHD is most commonly due to a decreased 
cross-sectional area of a muscle resulting from GH and T 
decline, the maintenance of FFM seems to play a key role in 
preventing the consequences of aging. A relationship was also 
revealed between GHD and a significant decrease in VO2max, 
and muscle strength [6]. Compared to individuals with normal 
ranges of GH, 40–50% of GH-deficient individuals exhibited 
changes in exercise capacity and a slight increase in LDL 
and total cholesterol concentrations [7]. Such abnormalities 
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underlie sarcopenia, insulin resistance, type 2 diabetes and 
cardiovascular disease. Prevention of age-related GH and 
T decline considerably slows down the aging process. As 
effort-related stimulation of GH or T secretion appears to 
be insufficient in elderly men, it is necessary to employ other 
methods of increasing GH and T concentrations. In healthy 
men, a 6-week testosterone therapy resulted in a body mass 
increase of 3–5 kg [8]. Testosterone inhibits triglyceride 
uptake and lipoprotein lipase activity. Similar to other 
androgens, testosterone has been shown to prevent or delay 
age-related cognitive impairment. Testosterone replacement 
for 12–24 weeks increased fat-free mass and muscle size 
in hypogonadal men by increasing protein synthesis and 
accretion [9]. Recombinant human growth hormone (rhGH) 
has also been shown to have noticeable effects. Salomon 
et al. [10] demonstrated that 6 months of growth hormone 
replacement (0.07 U per kilogram of body mass) caused mean 
lean body mass increase of 5.5 kg and fat mass decrease of 
5.7 kg. Cuneo et al. [11] documented a rhGH-induced increase 
in lean tissue and skeletal muscle mass/strength in adults 
with human GH deficiency. Although GH administration to 
GH-deficient adults increases fat-free mass and decreases fat 
mass [11], earlier studies employing GH as a lipolytic agent in 
the treatment of obesity have been disappointing [12]. Both 
GH and T have been used in the treatment of andropause 
and to reduce changes associated with aging.
The aim of this research project was to evaluate the effects 
of recombinant human growth hormone and testosterone 
enanthate injections on body mass and body composition, 
aerobic and anaerobic fitness and lipid profile in middle-
aged men.
MATERIALS AND METHOD
The research group comprised 14 men aged 45 – 60 years. 
Inclusion criteria were: age (45–60 yrs.), BMI (25–33), TBF 
(23–30%), diagnosed andropause and no contraindications to 
the procedures in this study. The participants were randomly 
allocated to 2 groups, ie., experimental and control group 
(Tab. 1). The experimental group was subjected to rhGH and 
testosterone oenanthate injections over a period of 12 weeks. 
RhGH was administered daily in progressive doses of up to 
30mg/kg of body mass. T was given once a week at a dose 
of 100 mg. The control group were given a placebo during 
the entire study period. Prior to the study and during the 
investigations the participants were placed on a isocaloric 
mixed diet (55% carbohydrates, 20% proteins, 25% fats).
Two series of laboratory analyses were performed. 
Independent tests were carried out at baseline and after 
12 weeks of the experiment.
Body mass and composition were determined between 
08.00 – 09.00 using bioelectrical impedance analysis 
(InBody 220). Body mass index (BMI), body mass (BM), 
total body fat (TBF), fat-free mass (FFM) and total body 
water (TBW) were registered. 10-ml blood samples were 
collected for biochemical determinations of growth hormone 
(GH), testosterone (T) and insulin-like growth factor 1 
(IGF-1). Triglyceride (TAG), total cholesterol (T-Ch), high-
density lipoprotein cholesterol (HDL-Ch) and low-density 
lipoprotein cholesterol (LDL-Ch) were also determined. 
Capillary blood samples were drawn to evaluate resting and 
post-exercise lactate concentrations (LA). GH concentrations 
were assayed by the the radioimmune method with a DSL-
1900 IRMA diagnostic kit (Diagnostic System Laboratories, 
Webster, TX, USA). Serum IGF-1 concentrations were also 
determined utilizing an immunoradiometric assay (IRMA) 
kit (DSL-2800 Active IGF-1, Diagnostic System Laboratories, 
Webster, TX, USA). Serum testosterone concentrations were 
evaluated using the immunoradiometric method with a 
DSL-1900 kit.
Test protocols. The exercise test used in evaluation of 
anaerobic fitness was the 30-second Wingate protocol 
performed on a cycle ergometer, with resistance of 0.08 Nm/kg 
body mass. Prior to the test, all participants had a 5-minute 
warm-up at 100 W and a pedal cadence of approximately 
70–80 revolutions per minute.
Following the warm-up, the 30-second test started, in 
which the objective was to reach the highest number of 
revolutions per minute in the shortest possible time, and to 
maintain the cadence as long as possible. After completion 
of the Wingate test, the cool-down resistance was set at 50W 
for 4 minutes. In order to determine lactate concentrations 
during rest and the 4th minute of the recovery, 1ml capillary 
blood samples were collected from fingertips.
The variables of maximal power – Pmax (W/kg) and total 
work performed – Wt (J/kg) were registered by the Lode 
Ergometry Manager (LEM) software package.
In order to determine aerobic fitness, each participant 
performed a ramp ergocycle test (T20x1) (20W/1min) with 
the work load increasing linearly (0.33W per 1s). Each test 
started at a resistance of 40 W and individually adjusted 
pedal cadence and lasted until volitional exhaustion and 
VO2max determination. Heart rate (HR), minute ventilation 
(VE), oxygen uptake (VO2), expired carbon dioxide (CO2), 
respiratory ratio (RER) and breath frequency (BF) were 
constantly monitored (MetaLyzer 3B‐ 2R, Cortex).
Maximal oxygen uptake (VO2max) and maximal work rate 
(Wrmax – W) were registered using the Lode Ergometry 
Manager (LEM) software package. The anaerobic threshold 
(AT) was determined by the V-slope method. All tests were 
performed on an electromagnetically braked ergocycle 
Excalibur Sport (Lode).
Training programme. All subjects taking part in the 
research participated in a 12-week fitness programme. The 
4-day-a-week training regimen included 2 days of strength 
training and 2 days of aerobic endurance exercise. The 
initial aerobic sessions consisted of 30-minute continuous 
pedaling on a stationary ergocycle at 70–75% HRmax. Every 
Table 1.  Characteristics of the tested subjects
Variables
Experimental groupa
(n=7)
Control groupa
(n=7)
Age [years] 48.36 ± 2.50 49.21 ± 3.50
Body height [cm] 184.0 ± 4.00 187.0 ± 4.00
Body mass [kg] 99.03 ± 14.02 99.54 ± 7.24
BMI [kg/m2] 30.50 ± 2.61 28.28 ± 2.97
TBF [kg] 26.08 ± 8.63 20.82 ± 5.86
FFM [kg] 72.90 ± 6.84 75.84 ± 8.78
a – mean value and standard deviation (SD), BMI – body mass index; TBF – Total body fat; FFM 
– fat-free mass; TBW – total body water
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2 weeks, the volume of work was increased by 5 minutes, 
thereby reaching 60 minutes during the last 2 weeks of the 
experiment. The muscular endurance training was focused 
on a holistic approach and consisted of multijoint exercises, 
such as the bench press, lat pulldown, dumbbell biceps curl, 
barbell squats, barbell upright row, and military press The 
training loads were progressively increased from 3 sets of 
each exercise to 4 and 5 sets in the successive months of the 
experiment.
Statistical analysis. The data were analyzed using Statistica 
9.1 software. The assumption of normality was verified using 
the Kolmogorov-Smirnov test. Comparison of the analyzed 
values before and after introduction of the experimental 
factor, was carried out with a two-way repeated measures 
ANOVA. When significant differences were found, Tukey‘s 
HSD post-hoc tests were used. The effect size (η2) of each 
test was calculated for all analyses and classified according 
to Hopkins [13]. Statistical significance was set at p<0.05.
RESULTS
Table 2 presents the pre- and post-intervention values of body 
composition and body mass variables. A two-way repeated 
measures ANOVA revealed a statistically significant effect of 
the intervention on FFM (η2=0.344) and TBF (η2=0.791). No 
significant post-intervention differences were observed in BM 
(η2=0.151), TBW (η2=0.094) and BMI (η2=0.114). Thus, FFM 
significantly increased while TBF decreased in comparison 
to the pre-intervention levels.
Table 3 presents pre- and post-intervention values of the 
biochemical variables under analysis. A two-way repeated 
measures ANOVA revealed statistically significant effect of 
the intervention programme on the following variables: T-Ch 
(η2=0.301), HDL-Ch (η2=0.314), LDL-Ch (η2=0.415), TAG 
(η2=0.284), T (η2=0.521), IGF-1 (η2=0.474), GH (η2=0.631).
The Tukey’s HSD post-hoc test revealed a statistically 
significant decrease of T-Ch (p=0.028) and increases in 
HDL-Ch (p=0.001), LDL-Ch (p=0.001), TAG (p=0.041), T 
(p=0.001), IGF-1 (p=0.006) and GH (p=0.001).
Table 4 presents pre- and post-intervention values 
of physical fitness related variables. A two-way repeated 
measures ANOVA revealed a statistically significant effect of 
the rhGH and T treatment on VO2max (η2=0.631), AT (η2=0.611) 
and WRmax (η2=0.531) while no statistically significant post-
intervention differences were observed in Wt (η2=0.128), 
Pmax (η2=0.108) and LA (η2=0.105). The Tukey’s HSD post-
hoc test revealed a statistically significant increase in VO2max 
(p=0.002), AT (p=0.005) and Wrmax (p=0.013).
DISCUSSION
Both GH and T stimulate protein synthesis and may exert an 
anabolic effect, thus potentially limiting muscle atrophy and 
other unfavourable changes in older individuals. Changes in 
BM, FFM and TBF resulting from rhGH alone, testosterone 
alone and combined rhGH+T have been mentioned in 
numerous reports [11, 14, 15, 16]. Rudman et al. [17] used 
rhGH for 6 months and revealed an 8.8% increase in lean 
body mass, yet most likely the noticeable gain in FFM resulted 
from rhGH-induced water-sodium retention rather than 
actual FFM increase [18].
Table 2. Pre- to post-intervention changes in body composition and body 
mass, and results of a two-way repeated measures ANOVA
Variables Group
Before (rhGH and 
T) X±SD
After (rhGH and T)
X±SD
F p
BM (kg)
I exp 99.03 ± 14.02 97.40 ± 13.72
1.151 0.121
II cont 99.54 ± 7.24 99.38 ± 3.57
TBF (kg)
I exp 26.08 ± 8.63 23.40 ± 8.74
79.941 0.015
II cont 20.82 ± 5.86 20.22 ± 5.93
FFM (kg)
I exp 72.90 ± 6.84 74.92 ± 5,46
9.481 0.008
II cont 85.84 ± 8.78 84,77 ± 8.26
TBW (kg)
I exp 53.65 ± 4.96 54.62 ± 4.09
0.073 0.790
II cont 62.74 ± 6.16 61.71 ± 14.39
BMI
I exp 30.50 ± 3.54 27.80 ± 2.61
1.250 0.270
II cont 28.28 ± 3.07 27.64 ± 3.14
Table 3. Lipoprotein profile and hormone concentrations before and after 
rhGH and T treatment with results of a two-way repeated measures ANOVA
Variables Group
Before (rhGH 
and T) X±SD
After (rhGH and T)
X±SD
F p
T-Ch (mg/dl)
I exp 216.46 ± 26.92 184.41 ± 21.25
 5.927 0.025
II cont 196.42 ± 26.85 192.36 ± 15.89
HDL-Ch (mg/dl)
I exp   74.52 ± 16.43   84.15 ± 19.78
 7.169 0.015
II cont   68.90 ± 4.33   65.57 ± 4.30
LDL-Ch (mg/dl)
I exp 114.82 ± 29.05 101.65 ± 27.06
12.231 0.021
II cont 127.63 ± 11.35 128.78 ± 8.75
TAG (mg/dl)
I exp 136.03 ± 58.20 122.12± 50.64
 3.729 0.043
II cont 113.38 ± 27.82 115.91 ± 26.84
GH (ng/ml)
I exp     0.49 ± 0.16     2.05 ± 0.86
23.261 0.001
II cont     0.58 ± 0.14     0.57 ± 0.12
IGF-1 (ng/ml)
I exp 184.45 ± 38.57 219.25 ± 27.23
13.25 0.001
II cont 191.98 ± 25.87 191.57 ± 23.85
T (nmol/l)
I exp   13.80 ± 3.81   26.47 ± 7.96
18.510 0.002
II cont   17.88 ± 5.14   17.64 ± 4.01
Table 4. Aerobic and anaerobic fitness before and after the rhGH and T   
treatment and results of a two-way repeated measures ANOVA
Variables Group
Before  
(rhGH and T)  
X±SD
After  
(rhGH and T)
X±SD
F p
Changes  
in 
aerobic 
fitness
VO2max
(ml/min/kg)
I exp   35.88 ± 5.45   40.27 ± 6.09
32.60 0.002
II cont   35.10 ± 6.65   35.84 ± 6.23
AT (W)
I exp 172.33 ± 23.23 190.67 ± 30.02
22.60 0.005
II cont 161.00 ± 23.13 162.14 ± 21.59
WRmax (W)
I exp 290.50 ± 32.79 308.55 ± 25.74
18.44 0.021
II cont 275. 56 ± 27.75 275.11 ± 29.27
Changes  
in 
anaerobic 
fitness
Wt (J/kg)
I exp 200.85 ± 31.79 210.27 ± 33.09
 1.99 0.061
II cont 198. 44 ± 27.75 198.48 ± 26.77
Pmax  
(W/kg)
I exp   16.22 ± 3.85   17.23 ± 3.70
 1.73 0.068
II cont   15.02 ± 1.62   15.37 ± 1.68
LA 4min 
(mmol)
I exp     7.61 ± 0.81     8.17 ± 1.17
 1.68 0.072
II cont     7.39 ± 0.72     7.40 ± 0.80
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In order to eliminate data misinterpretation in the 
presented study, not only BM, FFM and TBF were analysed, 
but also TBW. The experimental group receiving rhGH and 
T exhibited a significant increase of FFM and a decrease in 
TBF. No significant changes were observed regarding BM and 
TBW. TBF and FFM changes related to hormone replacement 
therapy usually occur during the first 6 months. The rhGH 
alone, T alone, and, a more effective combination of rhGH+T 
lead to changes in body composition [11], as confirmed by a 
number of investigations in which several very advantageous 
changes in FFM and TBF were found. Following a long-term 
rhGH replacement therapy, Chihara et al. [16] revealed a 
8.9% decrease in TBF in men compared to a placebo group. 
It might be of interest that after 24 and 48 weeks of rhGH 
treatment, overall changes in LBM, BFM and IGF-1 SD score 
were small, with no significant differences compared to the 
placebo participants. These results indicate that following a 
period during which rhGH replacement therapy does exert its 
metabolic effects, GH activity stabilizes and therapy outcome 
becomes reduced.
The presented study did not reveal any significant change 
in BM, which is consistent with the results of Jorgensen et al. 
[19], who did not observe significant post-rhGH changes in 
body mass, but did report significant alterations in body 
composition. The fact of this result having been reached on 
rhGH replacement alone may suggest that a TBF decrease 
found in the presented study may also have resulted from 
the rhGH treatment. There are reports indicating that T 
or GH replacement alone may cause changes in both 
body mass and body composition [15]. Testosterone and 
its therapeutic concentrations seem to exert a particularly 
noticeable effect on BM. Similar to our findings, Friedl et al. 
[14] did not find body mass changes in middle-aged men who 
received testosterone enanthate (TE) at a dose of 100mg/wk. 
Significant increases were observed only for men receiving a 
dose of 300mg/wk. Contrary results were presented by Griggs 
et al. [9], who showed no significant increase in muscle fibre 
diameter after 6 weeks of testosterone enanthate treatment.
The presented findings regarding the effects of combined 
rhGH+T therapy are consistent with the findings of Blackman 
et al. [20] who noted a decrease in TBF and an increase of 
FFM. Most of the effects of rhGH on FFM are mediated 
by increased production of IGF-1, which was previously 
observed by Yarasheski et al. [21]. An IGF-1 increase during 
rhGH replacement was also found in the current study. 
IGF-1 enhances amino acid uptake, promotes mRNA 
transcription and translation, possibly inhibits proteolysis, 
increases the number of muscle cell nuclei and stimulates 
muscle hypertrophy [22]. Both rhGH replacement as well as 
combined rhGH+T treatment result in a significant elevation 
of IGF-1 levels; thus, the role of this factor in fat-free mass 
increase cannot be unequivocally determined. A 4-week 
testosterone therapy administered to elderly men produced 
serum concentrations equal to those of younger men, 
increased mRNA concentrations of IGF-1 and decreased 
mRNA concentrations of insulin-like growth factor binding 
protein-4 [15]. These findings seem to confirm that increasing 
testosterone concentrations in elderly men increases skeletal 
muscle protein synthesis and strength, and that this increase 
may be mediated by stimulation of the intramuscular IGF-1 
system.
The subjects from the experimental group received rhGH 
and T injections, while all subjects taking part in the research 
project participated in a specifically designed physical fitness 
programme. Enhanced GH and T secretions in response to 
resistance training suggests that the latter might promote 
beneficial changes in body mass and composition. The 
subjects selected for this experiment were regularly engaged 
in different forms of physical exercise prior to enrolment; 
thus, the physical activity programme used in the study was 
a continuation of their healthy lifestyle. Yarasheski et al. 
[21] hypothesized that heavy-resistance exercise training in 
older men combined with rhGH replacement would enhance 
muscle protein anabolism. However, increments in the rate 
of muscle protein synthesis were similar in the rhGH and 
placebo groups. These observations suggest that resistance 
exercise alone is capable of improving muscle strength 
and anabolism which seems consistent with the presented 
findings since only rhGH+T participants exhibited significant 
changes in body mass composition including FFM. In the 
study of Bhasin et al. [2], increases in lean body mass were 
6.1 and 3.2 kg in the steroid-treated groups with and without 
resistance exercise, respectively. In the current study, the 
experimental group with rhGH+T treatment combined with 
resistance training showed significant increases in aerobic 
and anaerobic fitness, i.e., both VO2max and WRmax were 
increased. It seems that the improvement of aerobic fitness 
variables in the presented study (group I) was mainly due 
to testosterone therapy and the physical fitness programme. 
This seems consistent with the findings of Rodriguez-
Arnao et al. [23], whose data support the concept that GH 
therapy alone, in the absence of an exercise programme, 
may increase the amount of lean tissue, but not the quality 
or functional capacity of this tissue. Similar results were 
reported by Blackman et al. [20], who compared the effects of 
growth hormone and sex steroids alone to those of rhGH+T. 
The authors suggested that an increase in aerobic fitness 
resulting from rhGH+T injections might be associated with 
a relationship between VO2max and FFM. They concluded that 
an increase in VO2max was caused by an FFM gain and not 
by cardiac output. Observations in the presented study seem 
to confirm these findings since significant FFM and VO2max 
increases were only found in rhGH+T participants engaged 
in the resistance and endurance training programme.
Numerous researchers reported that rhGH treatment 
resulted in the improvement of both aerobic and anaerobic 
capacities [6]. The current investigations demonstrated a 
significant increase in anaerobic capacity (Wt – J/Kg), while 
no significant differences were found between in the anaerobic 
power (Pmax) of the experimental and control groups. The 
improvement in anaerobic fitness might have resulted from 
enhanced glycolysis and a statistically significant increase 
in FFM. Several research projects investigating the effects of 
androgen administration on muscular strength and power 
reported a beneficial influence of GH and T [2]. Muscle 
strength gain, and, in particular, a significant increase in 
FFM observed in the presented study, should have resulted 
in a increased Pmax. This, however, was not found due to the 
lack of exercises enhancing muscle power production. As 
an anaerobic fitness variable, Pmax is significantly correlated 
with muscular and neural adaptations, which become 
compromised in the aging process [24].
The aging process is inevitably associated with unfavourable 
changes in the lipid profile, which increase the risk of 
coronary heart disease. Unbalanced concentrations of total 
and LDL-cholesterol, triglycerides and apolipoprotein B are 
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caused by metabolic impairment, inappropriate eating habits 
and insufficient physical activity. The results presented here 
demonstrate positive changes in the majority of lipidogram 
components in the group receiving rhGH+T therapy. The 
experimental group exhibited a T-Ch decrease, HDL-Ch 
increase, and a significantly lowered LDL-Ch and TAG 
concentrations. Since both the experimental and control 
groups participated in the same training programme, it may 
be assumed that the changes were associated with the rhGH+T 
treatment. Testosteron decreases LDL-Ch concentrations; 
additional effects on lipidogram components depend on 
its doses and forms of administration. After 6-months 
administration of rhGH, Munzer et al. [25] noted a decrease 
in LDL-Ch but not in T-Ch, whereas rhGH+T decreased both 
LDL-Ch and T-Ch. He hypothesized that the post-rhGH+T 
decrease in TBF was caused by lowered T-Ch and LDL-Ch 
concentrations and not hormonal actions. Rodriguez-Arnao 
et al. [23] believed that rhGH+T treatment was particularly 
effective in the regulation of the lipid profile in overweight 
individuals, which was confirmed in the presented study. It 
should be emphasized that the lipid profile is affected not only 
by rhGH+T replacement therapy but also by physical activity. 
As opposed to other research projects, the presented study 
participants had been engaged in physical activity prior to 
recruitment. Thus, it may be suggested that changes in their 
lipid profiles were mostly due to the hormone replacement 
therapy.
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